Payment overview · 2025
General Payments
$40.65
2 reported records · 1 companies
Healthcare provider profile · identity verified
Michael Robert Reid, MD
Allopathic & Osteopathic Physicians|Family Medicine · LINCOLNTON, NC · NPI 1164784534
Verified facts
What the public records show
CMS Open Payments records show Michael Robert Reid, MD received $40.65 in general payments during 2025 across 2 reported records.
Novo Nordisk Inc accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 128 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 31 claims for Rybelsus by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $40.65 | 100.0% | 2 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $40.65 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $40.65 | 2 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
128 | 33 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
31 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 844 | 214 |
| Lisinopril | Lisinopril | 782 | 208 |
| Omeprazole | Omeprazole | 741 | 202 |
| Levothyroxine Sodium | Levothyroxine Sodium | 712 | 171 |
| Amlodipine Besylate | Amlodipine Besylate | 671 | 179 |
| Gabapentin | Gabapentin | 523 | 143 |
| Losartan Potassium | Losartan Potassium | 456 | 116 |
| Pravastatin Sodium | Pravastatin Sodium | 446 | 106 |
| Metformin Hcl Er | Metformin Hcl | 388 | 110 |
| Pantoprazole Sodium | Pantoprazole Sodium | 386 | 103 |
| Fluticasone Propionate | Fluticasone Propionate | 381 | 123 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 374 | 100 |
| Tramadol Hcl | Tramadol Hcl | 362 | 67 |
| Tamsulosin Hcl | Tamsulosin Hcl | 331 | 89 |
| Furosemide | Furosemide | 319 | 80 |
| Potassium Chloride | Potassium Chloride | 317 | 97 |
| Allopurinol | Allopurinol | 306 | 68 |
| Montelukast Sodium | Montelukast Sodium | 303 | 74 |
| Metoprolol Succinate | Metoprolol Succinate | 299 | 75 |
| Escitalopram Oxalate | Escitalopram Oxalate | 281 | 56 |
| Clonazepam | Clonazepam | 275 | 46 |
| Eliquis | Apixaban | 269 | 58 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 267 | 87 |
| Trazodone Hcl | Trazodone Hcl | 251 | 70 |
| Famotidine | Famotidine | 244 | 68 |
| Hydrochlorothiazide | Hydrochlorothiazide | 237 | 66 |
| Metoprolol Tartrate | Metoprolol Tartrate | 221 | 66 |
| Carvedilol | Carvedilol | 219 | 48 |
| Duloxetine Hcl | Duloxetine Hcl | 216 | 41 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 194 | 52 |
| Alprazolam | Alprazolam | 193 | 22 |
| Simvastatin | Simvastatin | 186 | 51 |
| Sertraline Hcl | Sertraline Hcl | 185 | 54 |
| Meloxicam | Meloxicam | 184 | 54 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 167 | 39 |
| Mirtazapine | Mirtazapine | 153 | 46 |
| Clopidogrel | Clopidogrel Bisulfate | 142 | 40 |
| Methylprednisolone | Methylprednisolone | 136 | 117 |
| Doxycycline Hyclate | Doxycycline Hyclate | 129 | 96 |
| Ozempic | Semaglutide | 128 | 33 |
| Tizanidine Hcl | Tizanidine Hcl | 128 | 30 |
| Fluoxetine Hcl | Fluoxetine Hcl | 126 | 33 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 120 | 42 |
| Atenolol | Atenolol | 119 | 27 |
| Buspirone Hcl | Buspirone Hcl | 118 | 27 |
| Metformin Hcl | Metformin Hcl | 116 | 33 |
| Baclofen | Baclofen | 114 | 33 |
| Tradjenta | Linagliptin | 113 | 25 |
| Lovastatin | Lovastatin | 106 | 27 |
| Pregabalin | Pregabalin | 105 | 27 |
| Bupropion Xl | Bupropion Hcl | 101 | 28 |
| Hydralazine Hcl | Hydralazine Hcl | 99 | 25 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 99 | 28 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 94 | 27 |
| Prednisone | Prednisone | 93 | 75 |
| Lorazepam | Lorazepam | 92 | 22 |
| Fenofibrate | Fenofibrate Nanocrystallized | 90 | 18 |
| Benazepril Hcl | Benazepril Hcl | 89 | 19 |
| Ondansetron Odt | Ondansetron | 87 | 37 |
| Alendronate Sodium | Alendronate Sodium | 84 | 22 |
| Citalopram Hbr | Citalopram Hydrobromide | 84 | 22 |
| Synthroid | Levothyroxine Sodium | 82 | 17 |
| Ipratropium Bromide | Ipratropium Bromide | 81 | 35 |
| Mounjaro | Tirzepatide | 81 | 26 |
| Azithromycin | Azithromycin | 79 | 74 |
| Ezetimibe | Ezetimibe | 79 | 23 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 77 | 42 |
| Ropinirole Hcl | Ropinirole Hcl | 75 | 14 |
| Diclofenac Sodium | Diclofenac Sodium | 74 | 24 |
| Finasteride | Finasteride | 74 | 23 |
| Naproxen | Naproxen | 74 | 32 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 73 | 21 |
| Jardiance | Empagliflozin | 71 | 20 |
| Celecoxib | Celecoxib | 70 | 20 |
| Linzess | Linaclotide | 70 | 11 |
| Spironolactone | Spironolactone | 66 | 20 |
| Xarelto | Rivaroxaban | 65 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 64 | 16 |
| Glimepiride | Glimepiride | 63 | 19 |
| Sucralfate | Sucralfate | 62 | 29 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 59 | suppressed |
| Ibuprofen | Ibuprofen | 56 | 14 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 56 | 15 |
| Promethazine Hcl | Promethazine Hcl | 56 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 56 | 18 |
| Pioglitazone Hcl | Pioglitazone Hcl | 55 | 15 |
| Zolpidem Tartrate | Zolpidem Tartrate | 55 | suppressed |
| Nystatin | Nystatin | 53 | 20 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 52 | 12 |
| Cephalexin | Cephalexin | 51 | 48 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 49 | 36 |
| Fenofibrate | Fenofibrate | 49 | 14 |
| Glipizide | Glipizide | 49 | 13 |
| Nebivolol Hcl | Nebivolol Hcl | 48 | suppressed |
| Diazepam | Diazepam | 47 | suppressed |
| Myrbetriq | Mirabegron | 47 | 11 |
| Aripiprazole | Aripiprazole | 46 | 12 |
| Doxazosin Mesylate | Doxazosin Mesylate | 46 | 15 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 46 | 12 |
| Donepezil Hcl | Donepezil Hcl | 45 | 16 |
| Solifenacin Succinate | Solifenacin Succinate | 44 | 12 |
| Symbicort | Budesonide/Formoterol Fumarate | 44 | 13 |
| Torsemide | Torsemide | 44 | 16 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 42 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 41 | 33 |
| Indapamide | Indapamide | 40 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 40 | 14 |
| Metoclopramide Hcl | Metoclopramide Hcl | 38 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 37 | 13 |
| Colestipol Hcl | Colestipol Hcl | 37 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 37 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 37 | 15 |
| Mupirocin | Mupirocin | 37 | 30 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 37 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 36 | 13 |
| Clonidine Hcl | Clonidine Hcl | 35 | suppressed |
| Topiramate | Topiramate | 35 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 35 | 12 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 34 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 34 | 16 |
| Farxiga | Dapagliflozin Propanediol | 33 | 14 |
| Ketoconazole | Ketoconazole | 32 | 14 |
| Quetiapine Fumarate | Quetiapine Fumarate | 32 | suppressed |
| Ramipril | Ramipril | 31 | suppressed |
| Rybelsus | Semaglutide | 31 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 30 | suppressed |
| Lamotrigine | Lamotrigine | 30 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 29 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 28 | 13 |
| Valacyclovir | Valacyclovir Hcl | 28 | 14 |
| Propranolol Hcl | Propranolol Hcl | 27 | suppressed |
| Temazepam | Temazepam | 26 | suppressed |
| Glipizide Er | Glipizide | 25 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 25 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 24 | suppressed |
| Telmisartan | Telmisartan | 24 | suppressed |
| Valsartan | Valsartan | 24 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 23 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 23 | 11 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 22 | suppressed |
| Amoxicillin | Amoxicillin | 22 | 19 |
| Colchicine | Colchicine | 22 | 11 |
| Novolog Flexpen | Insulin Aspart | 22 | suppressed |
| Risperidone | Risperidone | 22 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 22 | suppressed |
| Trijardy Xr | Empaglifloz/Linaglip/Metformin | 22 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 21 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 20 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 20 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 20 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 19 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 19 | suppressed |
| Verapamil Sr | Verapamil Hcl | 19 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 18 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 18 | suppressed |
| Digoxin | Digoxin | 18 | suppressed |
| Hydrocortisone | Hydrocortisone | 18 | 13 |
| Irbesartan | Irbesartan | 18 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 18 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 18 | 15 |
| Verapamil Er | Verapamil Hcl | 18 | suppressed |
| Dutasteride | Dutasteride | 17 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 17 | suppressed |
| Nitroglycerin | Nitroglycerin | 17 | 12 |
| Oxycodone Hcl | Oxycodone Hcl | 17 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 17 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 16 | suppressed |
| Chlorthalidone | Chlorthalidone | 16 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 16 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 16 | suppressed |
| Fluconazole | Fluconazole | 16 | 12 |
| Synjardy | Empagliflozin/Metformin Hcl | 16 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Memantine Hcl | Memantine Hcl | 15 | suppressed |
| Methocarbamol | Methocarbamol | 15 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 15 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Zafirlukast | Zafirlukast | 15 | suppressed |
| Clotrimazole | Clotrimazole | 14 | suppressed |
| Estradiol | Estradiol | 14 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 14 | suppressed |
| Ibu | Ibuprofen | 14 | suppressed |
| Lidocaine | Lidocaine | 14 | suppressed |
| Metronidazole | Metronidazole | 14 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 14 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 14 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 14 | suppressed |
| Pen Needles | Pen Needle, Diabetic | 14 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 13 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 13 | suppressed |
| Klor-Con M10 | Potassium Chloride | 13 | suppressed |
| Nifedipine Er | Nifedipine | 13 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 13 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 13 | suppressed |
| Sotalol | Sotalol Hcl | 13 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 13 | suppressed |
| Alcohol Pads | Alcohol Antiseptic Pads | 12 | suppressed |
| Olanzapine | Olanzapine | 12 | suppressed |
| Vascepa | Icosapent Ethyl | 12 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 11 | suppressed |
| Elmiron | Pentosan Polysulfate Sodium | 11 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 11 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 11 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 11 | suppressed |
| Invokana | Canagliflozin | 11 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 11 | suppressed |
| Klor-Con M20 | Potassium Chloride | 11 | suppressed |
| Levetiracetam | Levetiracetam | 11 | suppressed |
| Oxazepam | Oxazepam | 11 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $40.65 · 2 records | Novo Nordisk Inc | Wegovy | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error